50 likes | 59 Views
Multiplex Biomarker Imaging greatly helps to typify and examine the illness present in oneu2019s body. It is a useful technique, which carried out for determining the illness progress by using it in clinical studies. Medical industries require multiplex biomarkers in huge quantity.<br>Request a case study or sample research report at https://precisionbusinessinsights.com/request-sample?product_id=18950<br>
E N D
Multiplex Biomarker Imaging Market, 2021 - 2027 ©2021 Precision Business Insights Copyright ©Precision Business Insights 1
Market Overview: Multiplex Biomarker Imaging greatly helps to typify and examine the illness present in one’s body. It is a useful technique, which carried out for determining the illness progress by using it in clinical studies. Medical industries require multiplex biomarkers in huge quantity. These biomarkers can be utilized in alone or combination to assess as an indicator of biological process. Another great use of multiplex biomarkers is they help in studying biological system through analysis for checking the expression of different biomarkers. There are a number of factors that are predicted to drive the multiplex biomarker imaging market such as increasing R&D investments made by the key industries of the market, novelty of new technologies in biomarker imaging, growing adoption of multiplex biomarker in immunology and oncology research and increase in the demand for personalized medicine. Furthermore, as compared to conventional methods and growing inclination towards companion diagnostics are projected to foster the market during the forecast years 2021-2027. View Detailed Report Description ©2021 Precision Business Insights 2
Market Segments: The Global Multiplex Biomarker Imaging Market Has Been Fragmented Based On: 1. By Product Type : Instrument, Reagents and Kits, Software 2. By Imaging Technique : Tissue Microarray (TMA), Toponome Imaging System (TIS), Fluorescent In The Situ Hybridization (FISH), Immunofluorescence Assay (IF), Immunohistochemistry Assay (IHC) 3.By Application: Oncology, Immunology, Drug Safety, Drug Discovery 4. By End-User: Biotechnology and Pharmaceutical Companies, Academic Research Institutes, Contract Research Organizations 4. By Geography: North America, Asia Pacific, Europe, Middle East And Africa, Latin America Request Sample Report ©2021 Precision Business Insights 3
Key Players: Some of the major key players in the Multiplex Biomarker Imaging Market are: 1. Bio-rad Laboratories Inc. (U.S.), 2. Abcam plc. (U.K.), 3. Perkin Elmer, Inc. (U.S.), 4. Thermo Fisher Scientific, Inc. (U.S.), 5. Merck KGaA (Germany), 6. Aushon BioSystems Ltd. (U.S.), 7. ToposNomos Ltd (Germany), 8. Ventana Medical Systems, Inc. (U.S.), 9. Biomax Inc. (U.S.) 10. Quanterix (U.S.). Request Sample Report ©2021 Precision Business Insights 4
Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, #202, RVS Sree Homes, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad, India – 500084 Email: sales@precisionbusinessinsights.com Toll Free : +1-866-598-1553 ©2021 Precision Business Insights 5 ©2020 Precision Business Insights